Early propofol infusion syndrome following cerebral angiographic embolization for giant aneurysm repair: Case report

Journal of Neurosurgery

Volumn 106, Issue 2 SUPPL., 2007, Pages 139-142

  Westhout, Franklin D ^a   Muhonen, Michael G ^a,b   Nwagwu, Chiedozie I ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CHILDREN S HOSPITAL OF ORANGE COUNTY   (United States)

Author keywords

Balloon occlusion test; Intracranial aneurysm; Pediatric neurosurgery; Propofol; Therapeutic embolization

Indexed keywords

INTRAVENOUS ANESTHETIC AGENT; PROPOFOL;

ACIDOSIS; ANEURYSM; ARTICLE; ARTIFICIAL EMBOLISM; BALLOON OCCLUSION; BRAIN ANGIOGRAPHY; CAROTID ARTERY DISEASE; CASE REPORT; CHEMICALLY INDUCED DISORDER; FEMALE; FOLLOW UP; FORWARD HEART FAILURE; HUMAN; HYPOTENSION; INSTRUMENTATION; INTERNAL CAROTID ARTERY; INTERVENTIONAL RADIOLOGY; METHODOLOGY; PATHOLOGY; PRESCHOOL CHILD; SYNDROME; TACHYCARDIA; TIME;

ACIDOSIS; ANESTHETICS, INTRAVENOUS; ANEURYSM; BALLOON OCCLUSION; CARDIAC OUTPUT, LOW; CAROTID ARTERY DISEASES; CAROTID ARTERY, INTERNAL; CEREBRAL ANGIOGRAPHY; CHILD, PRESCHOOL; EMBOLIZATION, THERAPEUTIC; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOTENSION; PROPOFOL; RADIOGRAPHY, INTERVENTIONAL; SYNDROME; TACHYCARDIA; TIME FACTORS;

EID: 34347215427     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Baker MT, Naguib M: Propofol: the challenges of formulation. Anesthesiology 103:860-876, 2005 (Pubitemid 41415536)
2. Baumeister F, Oberhoffer R, Liebhaber GM, Kunkel J, Eberhardt J, Holthausen H, et al: Fatal propofol infusion syndrome in association with ketogenic diet. Neuropediatrics 35:250-252, 2004 (Pubitemid 39215606)
3. Bumpus NN, Sridar C, Kent UM, Hollenberg PF: The naturally occurring cytochrome P450 (P450) 2B6 K262R mutant of P450 2B6 exhibits alterations in substrate metabolism and inactivation. Drug Metab Dispos 33:795-802, 2005 (Pubitemid 40686633)
4. Ernest D, French C: Propofol infusion syndrome-report of an adult fatality. Anaesth Intensive Care 31:316-319, 2003 (Pubitemid 36805959)
5. Goodale D: Diprivan (propofol), Medwatch: The FDA Safety Information and Adverse Event Reporting Program: 2001 safety information summaries. Washington, DC: U.S. Food and Drug Administration, April 25, 2001 (Letter) (http://www.fda.gov/medwatch/safety/2001/diprivan-deardoc.pdf.) [Accessed 6 November 2006]
6. Haase R, Sauer H, Eichler G: Lactic acidosis following shortterm propofol infusion may be an early warning of propofol infusion syndrome. J Neurosurg Anesthesiol 17:122-123, 2005
7. Holzki J, Aring C, Gillor A: Death after re-exposure to propofol in a 3-year-old child: a case report. Paediatr Anaesth 14:265-270, 2004 (Pubitemid 38373065)
8. Kelly D, Goodale D, Williams J, Herr DL, Chappell ET, Rosner MJ, et al: Propofol in the treatment of moderate and severe head injury: a randomized, prospective double-blinded pilot trial. J Neurosurg 90:1042-1052, 1999 (Pubitemid 29241171)
9. Koch M, De Backer D, Vincent J: Lactic acidosis: an early marker of propofol infusion syndrome? Intensive Care Med 30:522, 2004 (Pubitemid 38375635)
10. MacLaren R, Wachsman BA, Swift DK, Kuhl DA: Warfarin resistance associated with intravenous lipid administration: discussion of propofol and review of the literature. Pharmacotherapy 17:1331-1337, 1997 (Pubitemid 27518050)
11. McKillop D, Wild MJ, Butters CJ, Simcock C: Effects of propofol on human hepatic microsomal cytochrome P450 activities. Xenobiotica 28:845-853, 1998 (Pubitemid 28446361)
12. Medical Economics Company: Diprivan (propofol) Injectable Emulsion, 10mg/ml, (AstraZeneca Pharmaceuticals, LP, Wilmington, DE), in Physicians' Desk Reference, ed 60. Montvale, NJ: Thompson PDR, 2006, p 676
13. Osaka Y, Inomata S, Tanaka E, Nakamura T, Honda K, Miyabe M, et al: Effect of propofol on ropivacaine metabolism in human liver microsomes. J Anesth 20:60-63, 2006 (Pubitemid 43125786)
14. Polaner DM: Sedation-analgesia in the pediatric intensive care unit. Pediatr Clin North Am 48:695-714, 2001
15. Relling MV: Polymorphic drug metabolism. Clin Pharm 8:852-863, 1989
16. Vasile B, Rasulo F, Candiani A, Latronico N: The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome. Intensive Care Med 29:1417-1425, 2003 (Pubitemid 37153585)
17. Vernooy K, Delhaas T, Cremer OL, Di Diego JM, Oliva A, Timmermans C, et al: Electrocardiographic changes predicting sudden death in propofol-related infusion syndrome. Heart Rhythm 3:131-137, 2006 (Pubitemid 43149982)
18. Vuyk J: Clinical interpretation of pharmacokinetic and pharmacodynamic propofol-opioid interactions. Acta Anaesthesiol Belg 52:445-451, 2001
19. Wessel N, Schirdewan A: Toward a prediction of sudden death in propofol-related infusion syndrome. Heart Rhythm 3: 138-139, 2006 (Pubitemid 43149983)
20. Wolf A, Weir P, Segar P, Stone J, Shield J: Impaired fatty acid oxidation in propofol infusion syndrome. Lancet 357:606-607, 2001 (Pubitemid 32179617)